Invitation to Roche ’s Virtual Neurology Investor Event
We are pleased to invite investors and analysts to participate in our virtual event onMonday,11 March 2024, highlighting key data presented at 2024 Muscular Dystrophy Association (MDA) and Alzheimer ' s& Parkinson ' s Diseases (AD/PD) conferences. 15:00 – 16:30 CET / 14:00 – 15:30 GMT10:00 – 11:30 AM EDT / 07:00 – 08:30 AM PDT The webinar will start with presentations, followed by a Q&A session (live access to the speakers). The slides will be available for download at 14:00 CET on the day of the event.>click here Access to virtual event (pre-registration required)Please pre-register for our webinarhere.* Should you be unable to register for the webinar due to your company IT policy, please send an email toinvestor.relations@roche.com. A replay of the webinar will be available via>ir.roche.com*privacy notice Best regards, Bruno EschliHead of Investor Relations Loren KalmHead of Investor Relations, North America Roche Investor Relations Dr. Bruno EschliPhone: +41 61 68-75284e-mail:bruno.eschli@roche.com Dr. Sabine Borngr äberPhone: +41 61 68-88027e-mail:sabine.borngraeber@roche.com Dr. Birgit MasjostPhone: +41 61 68-84814e-mail:birgit.masjost@roche.com Investor Relations North America Loren KalmPhone: +1 650 225 3217e-mail:kalm.loren@gene.com
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news
More News: Alzheimer's | Brain | Conferences | Genetics | Muscular Dystrophy | Neurology | Parkinson's Disease | Pharmaceuticals | Reflex Sympathetic Dystrophy